The negative costimulatory molecule PD‐1 modulates the balance between immunity and tolerance via miR‐21
Open Access
- 16 March 2011
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 41 (6) , 1754-1763
Abstract
Disruption of the programmed death‐1 (PD‐1) pathway leads to breakdown of peripheral tolerance and initiation of autoimmunity. The molecular pathways that mediate this effect remain largely unknown. We report here that PD‐1 knockout (PD‐1−/−) mice develop more severe and sustained Ag‐induced arthritis (AIA) than WT animals, which is associated with increased T‐cell proliferation and elevated levels of IFN‐γ and IL‐17 secretion. MicroRNA analysis of Ag‐specific CD4+ T cells revealed a significant upregulation of microRNA 21 (miR‐21) in PD‐1−/− T cells compared with WT controls. In addition, PD‐1 inhibition, via siRNA, upregulated miR‐21 expression and enhanced STAT5 binding in the miR‐21 promoter area. Computational analysis confirmed that miR‐21 targets directly the expression of programmed cell death 4 (PDCD4) and overexpression of miR‐21 in cells harboring the 3′UTR of PDCD4 resulted in reduced transcription and PDCD4 protein expression. Importantly, in vitro delivery of antisense‐miR‐21 suppressed the Ag‐specific proliferation and cytokine secretion by PD‐1−/− T cells, whereas adoptive transfer of Ag‐specific T cells, overexpressing miR‐21, induced severe AIA. Collectively, our data demonstrate that breakdown of tolerance in PD‐1−/− mice activates a signaling cascade mediated by STAT5, miR‐21, and PDCD4 and establish their role in maintaining the balance between immune activation and tolerance.Keywords
This publication has 40 references indexed in Scilit:
- Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosusArthritis & Rheumatism, 2008
- Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathwaysImmunological Reviews, 2008
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetesProceedings of the National Academy of Sciences, 2005
- A PD‐1 polymorphism is associated with disease progression in multiple sclerosisAnnals of Neurology, 2005
- Association of the PD‐1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitopeArthritis & Rheumatism, 2004
- Association of a putative regulatory polymorphism in the PD‐1 gene with susceptibility to type 1 diabetesTissue Antigens, 2003
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001
- Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying ImmunoreceptorImmunity, 1999
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4Immunity, 1995